Variant report
Variant | nsv559100 |
---|---|
Chromosome Location | chr12:59969179-59970631 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:59970227..59972157-chr12:59989473..59991716,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000118596 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10747847 | chr12:59969179-59969180 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs576801556 | chr12:59969202-59969203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs80107517 | chr12:59969235-59969236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560881872 | chr12:59969252-59969253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146982901 | chr12:59969263-59969264 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542872616 | chr12:59969269-59969270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs137998756 | chr12:59969285-59969286 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10747848 | chr12:59969312-59969313 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs10747849 | chr12:59969332-59969333 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs61936275 | chr12:59969334-59969335 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs79164747 | chr12:59969366-59969367 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377675291 | chr12:59969400-59969401 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547469875 | chr12:59969424-59969425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187394138 | chr12:59969472-59969473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536561914 | chr12:59969473-59969474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10783988 | chr12:59969474-59969475 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs386763465 | chr12:59969482-59969483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10783989 | chr12:59969483-59969484 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs148199921 | chr12:59969502-59969503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576855285 | chr12:59969522-59969523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541068325 | chr12:59969533-59969534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552702744 | chr12:59969595-59969596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368677903 | chr12:59969596-59969597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542933999 | chr12:59969677-59969678 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561223565 | chr12:59969708-59969709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553584785 | chr12:59969719-59969720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34331285 | chr12:59969739-59969740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60632928 | chr12:59969765-59969766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543599470 | chr12:59969779-59969780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565421545 | chr12:59969844-59969845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532505370 | chr12:59969853-59969854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547831943 | chr12:59969859-59969860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112952238 | chr12:59969873-59969874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34616470 | chr12:59969874-59969875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs11173088 | chr12:59969901-59969902 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs530090797 | chr12:59969920-59969921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6581255 | chr12:59969968-59969969 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs182858559 | chr12:59969984-59969985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141479884 | chr12:59970053-59970054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74095610 | chr12:59970126-59970127 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs6581256 | chr12:59970132-59970133 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs188914561 | chr12:59970166-59970167 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563244765 | chr12:59970188-59970189 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111956078 | chr12:59970233-59970234 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs574122575 | chr12:59970275-59970276 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs533796570 | chr12:59970312-59970313 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs369080963 | chr12:59970315-59970316 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs74095612 | chr12:59970332-59970333 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs554881217 | chr12:59970397-59970398 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs6581257 | chr12:59970403-59970404 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:59961800-59970600 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
2 | chr12:59968200-59969200 | Enhancers | Hela-S3 | cervix |
3 | chr12:59968600-59970600 | Weak transcription | Dnd41 | blood |
4 | chr12:59968800-59969200 | Weak transcription | Primary T cells from cord blood | blood |
5 | chr12:59969000-59970600 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
6 | chr12:59969000-59970800 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
7 | chr12:59969200-59971800 | Enhancers | Primary T cells from cord blood | blood |
8 | chr12:59969400-59969600 | Enhancers | Fetal Thymus | thymus |
9 | chr12:59969600-59969800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr12:59969600-59970200 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr12:59969800-59972200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
12 | chr12:59970000-59971200 | Weak transcription | Fetal Thymus | thymus |
13 | chr12:59970200-59973400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
14 | chr12:59970600-59972000 | Enhancers | Dnd41 | blood |
15 | chr12:59970600-59972800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
16 | chr12:59970600-59973600 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |